- Home
- RFMZ vs SOPH Comparison
RFMZ vs SOPH Comparison
Compare RFMZ & SOPH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | RFMZ | SOPH |
|---|---|---|
| Founded | N/A | 2011 |
| Country | United States | Switzerland |
| Employees | N/A | N/A |
| Industry | Trusts Except Educational Religious and Charitable | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 317.8M | 374.1M |
| IPO Year | 2020 | 2021 |
Fundamental Metrics
Financial Performance| Metric | RFMZ | SOPH |
|---|---|---|
| Price | $12.97 | $5.27 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 2 |
| Target Price | N/A | ★ $7.50 |
| AVG Volume (30 Days) | 58.4K | ★ 82.4K |
| Earning Date | 01-01-0001 | 05-05-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | $23.09 |
| Revenue Next Year | N/A | $19.57 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $12.30 | $2.59 |
| 52 Week High | $13.27 | $5.70 |
Technical Indicators
Market Signals| Indicator | RFMZ | SOPH |
|---|---|---|
| Relative Strength Index (RSI) | 49.13 | 60.72 |
| Support Level | $12.78 | $4.56 |
| Resistance Level | $13.19 | $5.30 |
| Average True Range (ATR) | 0.09 | 0.25 |
| MACD | -0.01 | 0.02 |
| Stochastic Oscillator | 36.36 | 68.32 |
Price Performance
Historical ComparisonAbout RFMZ RiverNorth Flexible Municipal Income Fund II Inc.
RiverNorth Flex Muni Income Fund II Inc is a diversified, closed-end management investment company. Its primary investment objective is to seek current income exempt from regular U.S. federal income taxes. The fund's secondary investment objective is total return.
About SOPH SOPHiA GENETICS SA
Sophia Genetics SA is a healthcare technology company dedicated to establishing the practice of data-driven medicine as the standard of care and for life sciences research. It has built a cloud-based SaaS platform capable of analyzing data and generating insights from complex multimodal data sets and different diagnostic modalities. The Company had a physical presence in three countries outside of its headquarters in Switzerland: France, the United States, and Brazil.